Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01878045
What this trial is testing

Mechanisms of Diabetic Kidney Disease in American Indians

Who this might be right for
Nervous SystemDiabetic Kidney DiseaseDiabetes Mellitus, Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 141
Not applicableNot Yet RecruitingNCT07173686
What this trial is testing

Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT03899883
What this trial is testing

Uric Acid Lowering Trial in Youth Onset T2D

Who this might be right for
Diabetic Kidney DiseaseHyperuricemiaDiabetes+5 more
University of Colorado, Denver 11
Not applicableLooking for participantsNCT06936670
What this trial is testing

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Seattle Children's Hospital 90
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Large-scale testing (Phase 3)Study completedNCT01316094
What this trial is testing

Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 165
Not applicableUnknownNCT04799925
What this trial is testing

Hyperuricemia and Diabetic Nephropathy

Who this might be right for
HyperuricemiaDiabetic Nephropathies
Assiut University 200
Not applicableStudy completedNCT06332378
What this trial is testing

Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients

Who this might be right for
Diabetic Nephropathy Type 2
Dr. Sobia Hasan 90
Testing effectiveness (Phase 2)Study completedNCT04515849
What this trial is testing

Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Diseases
AstraZeneca 248
Not applicableStudy completedNCT05021705
What this trial is testing

Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic Patients

Who this might be right for
Diabetic Kidney Disease
Assiut University 60
Not applicableActive Not RecruitingNCT05282680
What this trial is testing

The Hong Kong Diabetes Biobank

Who this might be right for
Diabetes MellitusType 2 DiabetesType 1 Diabetes+8 more
Chinese University of Hong Kong 48,000
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Not applicableStudy completedNCT03889236
What this trial is testing

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Who this might be right for
Diabetic Nephropathy Type 2AlbuminuriaType2 Diabetes Mellitus+7 more
Leiden University Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT04534439
What this trial is testing

Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy

Who this might be right for
Diabetic NephropathiesDiabetes Mellitus, Type 2Nephropathy, Diabetic
Aptabio Therapeutics, Inc. 140
Post-approval studies (Phase 4)UnknownNCT04061200
What this trial is testing

Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria

Who this might be right for
Type 2 Diabetes With Renal Manifestations
Steno Diabetes Center Copenhagen 80
Not applicableLooking for participantsNCT04802395
What this trial is testing

Real World Evidence Clinical Utility Study of KidneyIntelX

Who this might be right for
Chronic Kidney DiseasesDiabetic Kidney Disease
Renalytix AI, Inc. 10,000
Not applicableActive Not RecruitingNCT05198284
What this trial is testing

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney DiseasesChronic Kidney Disease Stage 1+2 more
Renalytix AI, Inc. 2,000
Not applicableStudy completedNCT05378282
What this trial is testing

Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics

Who this might be right for
Type 2 DiabetesType 2 Diabetes With Renal Manifestations
Hospital Juarez de Mexico 40
Testing effectiveness (Phase 2)Study completedNCT01399580
What this trial is testing

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 48
Post-approval studies (Phase 4)Study completedNCT00742976
What this trial is testing

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

Who this might be right for
Diabetes Type 2Weight Gain
Rigshospitalet, Denmark 24
Next Page